COST · News · 20260801N
Pharmacy Demand: GLP-1 Medication Tailwind
COSTCO WHOLESALE CORP /NEW · 2026-08-01 · Importance 30 · Surprise 42 · In source text
As employers reduce coverage for GLP-1 medications, more U.S. consumers are being directed toward direct-to-consumer weight-loss prescription programs. Costco, Walmart, Amazon, CVS, and other pharmacy retailers are positioning themselves to fill the coverage gap and capture prescription demand. The shift could increase Costco’s pharmacy and ancillary-business opportunity while placing additional pressure on independent pharmacies.
Key facts
- As employers drop GLP-1 coverage, major retailers and pharmacy chains including Costco are racing to fill the void in direct-to-consumer weight-loss drug prescription programs. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | contingent | — | As employers drop GLP-1 coverage, major retailers and pharmacy chains including Costco are racing to fill the void in direct-to-consumer… |